$0.72
arrow_drop_down4.00%Key Stats | |
---|---|
Open | $0.79 |
Prev. Close | $0.80 |
EPS | -1.38 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $170.53M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.72 | 0.80 |
52 Week Range | 0.29 | 1.48 |
Ratios | |
---|---|
Revenue | - |
EPS | -1.38 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology
Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform